Alpa Laboratories Ltd
Alpa Laboratories Ltd Share Price Today: Live Updates & Key Insights
Get insights on Alpa Laboratories Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Alpa Laboratories Ltd Share Price Chart
ALPA at 10 Jul 2026 05:59 PM Biotechnology
68.25 -0.04(-0.06%)
Lowest Today 68.00
Highest Today 68.89
Today's Open 68.21
Prev. Close 68.29
52 Week High 120.50
52 Week Low 46.10
Alpa Laboratories Ltd Fundamentals
Traded Volume: 3,765
Market Cap(Cr): 143.60
Avg Traded Price 68.29
1 Year return -34.30%
Upper Circuit 68.9
Lower Circuit 68
P/E TTM 10.00
P/B Ratio 0.771
Traded Value(Cr) 2.57
EPS TTM 6.788
Book value/Share 88.530
Dividend Yield 1Y 0.00%
Alpa Laboratories Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Alpa Laboratories Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Alpa Laboratories Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -1.22%
1M -1.60%
3M -1.60%
1Y -34.30%
YTD -13.38%
Alpa Laboratories Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Alpa Laboratories Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 8827.00
Day Before Yesterday 14305.00
1W Avg 7743.80
1M Avg 14120.76
3M Avg 15611.08
Alpa Laboratories Ltd Technical Details
Alpa Laboratories Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 68
Support 2 67
Support 3 67
Pivot Point : 68
Resistance 1 69
Resistance 2 69
Resistance 3 70
Alpa Laboratories Ltd Corporate Actions
Alpa Laboratories Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Alpa Laboratories Ltd’s capital allocation strategies.
All
Dividends
No Dividend has been declared by ALPA
Bonus
No Bonus has been declared by ALPA
Splits
No Split has been declared by ALPA
Others
Rights No Rights has been declared by ALPA
Alpa Laboratories Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Alpa Laboratories Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Alpa Laboratories Ltd's relative performance and valuation against major competitors.
Stock Name Advanced Enzyme Technologies Ltd ₹329.85 (+1.70%) M. Cap (Cr) 36.94 1 Yr Return (%) +1.55% P/E (TTM) 21.89 PB Ratio 2.26
Stock Name Panacea Biotec Ltd ₹546.60 (-1.55%) M. Cap (Cr) 33.48 1 Yr Return (%) +30.52% P/E (TTM) -623.46 PB Ratio 4.01
Stock Name CCME Global Ltd ₹114.95 (-4.96%) M. Cap (Cr) 5.20 1 Yr Return (%) +391.45% P/E (TTM) -209.09 PB Ratio 19.11
Stock Name Alpa Laboratories Ltd ₹68.25 (-0.06%) M. Cap (Cr) 1.44 1 Yr Return (%) -34.30% P/E (TTM) 10.05 PB Ratio 0.77
Stock Name Bharat Immunological & Biological Corporation Ltd ₹17.02 (+2.65%) M. Cap (Cr) 0.73 1 Yr Return (%) -28.49% P/E (TTM) -3.98 PB Ratio 0.84
Stock Name Vivo Bio Tech Ltd ₹23.51 (+1.69%) M. Cap (Cr) 0.52 1 Yr Return (%) -33.70% P/E (TTM) -22.24 PB Ratio 0.44
Stock Name Shree Ganesh Biotech India Ltd ₹0.54 (0.00%) M. Cap (Cr) 0.22 1 Yr Return (%) -37.21% P/E (TTM) 41.86 PB Ratio 0.34
Alpa Laboratories Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Alpa Laboratories Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 11.48 Mar 2025 18.39 Mar 2024 3.70 Mar 2023 8.82 Mar 2022 2.20
PARTICULARS Investing Activities Mar 2026 -11.58 Mar 2025 -12.49 Mar 2024 -12.45 Mar 2023 2.14 Mar 2022 -17.18
PARTICULARS Financing Activities Mar 2026 -1.16 Mar 2025 -5.48 Mar 2024 2.26 Mar 2023 -3.48 Mar 2022 5.41
PARTICULARS Net Cash Flow Mar 2026 -1.26 Mar 2025 0.43 Mar 2024 -6.49 Mar 2023 7.48 Mar 2022 -9.57
Alpa Laboratories Ltd Shareholding Pattern
This shows the ownership breakdown of Alpa Laboratories Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 57.19%
Public 42.43%
Other Institutions 0.0%
FII 0.38%
Mutual Funds N/A%
About Alpa Laboratories Ltd
M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company as 'Alpa Laboratories Private Limited' on March 18, 1988 for manufacture of pharmaceutical formulations. In 1998, the Company was converted into a Public Limited with effect from September 3, 1998. The facility has manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels.In 1997, the Company initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The Unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark Alpa which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, the company has also undertaken contract manufacturing of a large variety of pharmaceuticals.The company has manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and mini metro cities, which enable company to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division.The Company came out with an Initial Public Offer in July 2007 and got listed on The n The Bombay Stock Exchange and The National Stock Exchange on 06lh August, 2008.The Unit-II oral solid dosage manufacturing facility focusing on containment products such as oral hormonal and other oral hi-potency formulations was made operational at Pithampur Industrial Area in 2012.The Company in FY 2014-15, acquired 100% of the shares of Norfolk Mercantile Private Limited making it a wholly owned subsidiary.Application for merger of Norfolk Mercantile Private Limited, Wholly owned subsidiary of the Company was filed before NCLT, Mumbai by Norfolk Mercantile Private Limited on 7th December, 2017.The same is pending before the Bench in 2025.
Chairman & Exec. Director
Mahendra Singh Chawla
Registered office 33/2 Pigdamber, A B Road Rau, Indore, Madhya Pradesh, 453446
FAX :91-731-4294567
Background
Incorporation Year 1988
Face Value ₹10.00
Market Lot 1
FAQs on Alpa Laboratories Ltd
How to buy Alpa Laboratories Ltd shares?
To buy Alpa Laboratories Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Alpa Laboratories Ltd?
The company has a market capitalization of ₹143.60.
What is the PE & PB ratio of Alpa Laboratories Ltd?
PE is 10 and PB is 0.771.
What is the Alpa Laboratories Ltd dividend for 2025–26?
For the 2025–26 financial year, Alpa Laboratories Ltd declared a final dividend of 0.00% per share.